Elrazi Ali
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Platelet Disorders and Treatments
-
- Diabetes and associated disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Genetics 23
- Myeloproliferative Neoplasms: Diagnosis and Treatment 14
- Hemoglobinopathies and Related Disorders 7
- Chronic Lymphocytic Leukemia Research 6
- Hematology 22
- Chronic Myeloid Leukemia Treatments 14
- Acute Myeloid Leukemia Research 4
- Co-authors
- Mohamed A. Yassin (36 shared papers)Abdulqadir J. Nashwan (4 shared papers)Mohammed Danjuma (2 shared papers)Zohaib Yousaf (1 shared paper)Fateen Ata (1 shared paper)Elmukhtar Habas (3 shared papers)Adeel Ahmad Khan (1 shared paper)Vincenzo De Sanctis (1 shared paper)
- Journals
- Blood (4 papers)Medicine (2 papers)Cancers (2 papers)Oncology (2 papers)Blood Advances (1 paper)
- Partner nations
- QatarUnited StatesSudan
In The Last Decade
Elrazi Ali
48 papers receiving 301 citations
Peers
Comparison fields: 5 of 61
- Hematology 73
- Genetics 50
- Infectious Diseases 48
- Endocrinology, Diabetes and Metabolism 41
- Nephrology 16
Countries citing papers authored by Elrazi Ali
This map shows the geographic impact of Elrazi Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elrazi Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elrazi Ali more than expected).
Fields of papers citing papers by Elrazi Ali
This network shows the impact of papers produced by Elrazi Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elrazi Ali. The network helps show where Elrazi Ali may publish in the future.
Co-authors
The 25 scholars most cited alongside Elrazi Ali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 53 | |
| 2 | 2020 | 33 | |
| 3 | 2022 | 16 | |
| 4 | 2021 | 16 | |
| 5 | 2021 | 15 | |
| 6 | 2020 | 15 | |
| 7 | 2020 | 13 | |
| 8 | 2022 | 12 | |
| 9 | 2020 | 10 | |
| 10 | 2021 | 10 | |
| 11 | 2022 | 9 | |
| 12 | 2023 | 9 | |
| 13 | 2015 | 8 | |
| 14 | 2021 | 8 | |
| 15 | 2022 | 6 | |
| 16 | 2022 | 6 | |
| 17 | 2021 | 5 | |
| 18 | 2024 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2023 | 3 |
About Elrazi Ali
Elrazi Ali is a scholar working on Genetics, Hematology, Surgery, Rheumatology and Infectious Diseases, having authored 58 papers that have together received 303 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), Chronic Myeloid Leukemia Treatments (14 papers), Hemoglobinopathies and Related Disorders (7 papers), Eosinophilic Disorders and Syndromes (7 papers), COVID-19 Clinical Research Studies (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Myeloid Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (73 citations), Genetics (50 citations), Infectious Diseases (48 citations), Endocrinology, Diabetes and Metabolism (41 citations) and Nephrology (16 citations). Elrazi Ali has collaborated with scholars based in Qatar, United States and Sudan. Frequent co-authors include Mohamed A. Yassin, Abdulqadir J. Nashwan, Mohammed Danjuma, Zohaib Yousaf, Fateen Ata, Elmukhtar Habas, Adeel Ahmad Khan, Vincenzo De Sanctis, Abdel‐Naser Elzouki and Ashraf Soliman. Their work appears in journals such as Blood, Medicine, Cancers, Oncology and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.